I’ve had the honor of working with Dr. Duane Mitchell and serving on the advisory council board for the Remission Alliance located in Gainesville, FL. Dr. Duane Mitchell is truly a one-of-a-kind luminary who is bringing together some of the brightest minds in the world to find a cure for brain tumors. Over the past five years, the center he leads has established itself as a national leader in cutting-edge brain tumor treatments, research, and hope.
The Remission Alliance is the overarching vision—an unprecedented, transitional, multi-disciplinary, and multi-partner consortium that aims to unify the world’s leading experts in neuro-oncology, immunology, genetics, artificial intelligence, and more. Under Dr. Mitchell’s visionary leadership, the Remission Alliance will leverage groundbreaking advances in brain tumor immunotherapy from leading scientists to dramatically accelerate the development of new treatments.
To date, the Remission Alliance has transformed the landscape of brain tumor research and treatment. The consortium is designed to foster collaboration and innovation by bringing together experts from various fields to tackle the complexities of brain tumors. This collaborative approach ensures that the most promising research and treatments are fast-tracked from the lab to the clinic, giving patients access to cutting-edge therapies as quickly as possible.
Dr. Mitchell’s laser-focused commitment to ending the status quo of “No Evidence of Disease” (NED) until a cure is found is both inspiring and critical. Parents of children with brain tumors currently hear NED as the best possible outcome, but Dr. Mitchell and the Remission Alliance are dedicated to finding a definitive cure.
Under Dr. Mitchell’s guidance, the Remission Alliance has made significant strides in developing new immunotherapeutic strategies that harness the power of the body’s immune system to target and destroy cancer cells. These innovative approaches are showing great promise in clinical trials and offer new hope for patients who previously had limited treatment options.
The Remission Alliance is not just about scientific and medical breakthroughs; it’s also about the human impact. The consortium’s work provides hope and support to patients and their families, offering them the possibility of a future free from the fear and uncertainty of brain tumors.
In addition to his groundbreaking work with the Remission Alliance, Dr. Mitchell is also a dedicated NEDvocate for patient-centered care. He believes that involving patients and their families in the research process is crucial for developing treatments that are not only effective but also tailored to the needs and preferences of those affected by brain tumors.
Dr. Duane Mitchell’s passion, dedication, and innovative approach to brain tumor research make him a beacon of hope for patients and families worldwide. The Remission Alliance, under his leadership, is poised to make unprecedented progress in the fight against brain tumors, bringing us closer to the day when NED is replaced with a cure.
As FOJ continues our work with the Remission Alliance, I am filled with optimism and gratitude for the opportunity to be part of this transformative journey. Together, we can achieve a future where brain tumors are no longer a threat to the lives and futures of children and adults alike. Dr. Mitchell is not only a brilliant, compassionate scientist but truly embodies the spirit of a NEDvocate!